Evaluation of de-O-acetylated meningococcal C polysaccharide-tetanus toxoid conjugate vaccine in infancy: Reactogenicity, immunogenicity, immunologic priming, and bactericidal activity against O-acetylated and de-O-acetylated serogroup C strains

Infection and Immunity

Volumn 69, Issue 4, 2001, Pages 2378-2382

  Richmond, Peter ^a,b   Borrow, Ray ^c   Findlow, Jamie ^c   Martin, sarah ^c   Thornton, Carol ^d   Cartwright, Keith ^e   Miller, Andelizabeth ^a  

^a Public Health Laboratory Service

^b Institute of Child Health

^c WITHINGTON HOSPITAL   (United Kingdom)

^d Porton Down   (United Kingdom)

^e GLOUCESTERSHIRE ROYAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL POLYSACCHARIDE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; IMMUNOGLOBULIN G; ORAL POLIOMYELITIS VACCINE; TETANUS TOXOID;

ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ARTICLE; DRUG ACETYLATION; HAEMOPHILUS INFLUENZAE TYPE B; HUMAN; IMMUNIZATION; IMMUNOGENICITY; IMMUNOGLOBULIN PRODUCTION; IMMUNOLOGICAL MEMORY; INFANT; MAJOR CLINICAL STUDY; MENINGOCOCCOSIS; NEISSERIA MENINGITIDIS; PRIORITY JOURNAL; SERUM BACTERICIDAL ACTIVITY;

EID: 0035077458     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.69.4.2378-2382.2001     Document Type: Article

References (33)

1. Anonymous.2000. Meningococcal disease falls in vaccine recipients. Com-mun. Dis. Rep. Wkly.10:133–136
2. Arakere, G., and C. E. Frasch.1991. Specificity of antibodies to O-acetyl-positive and O-acetyl-negative group C meningococcal polysaccharides insera from vaccinees and carriers. Infect. Immun.59:4349–4356
3. Artenstein, M. S., R. Gold,, J. G. Zimmerly, F. A. Wyle, H. Schneider, and C.Harkins.1970. Prevention of meningococcal disease by group C polysaccha-ride vaccine. N. Engl. J. Med.282:417–420
4. Begg, N. T., E. Miller, C. K. Fairley, et al.1995. Antibody responses andsymptoms after DTP and either tetanus or diphtheriaHaemophilus influen-zaetype B conjugate vaccines given for primary immunisation by separate ormixed injection. Vaccine13:1547–1550
5. Booy, R., P. T. Heath, M. P. Slack, N. Begg, and R. Moxon.1997. Vaccinefailures after primary immunisation withHaemophilus influenzaetype b-conjugate vaccine without booster. Lancet349:1197–1202
6. Borrow, R., E. Longworth, S. J. Gray, and E. B. Kaczmarski.2000. Preva-lence of de-O-acetylated serogroup C meningococci before the introductionof meningococcal serogroup C conjugate vaccines in the United Kingdom.FEMS Immunol. Med. Microbiol.28:189–191.
7. Borrow, R., P. Richmond, E. B. Kaczmarski, et al.2000. Meningococcalserogroup C-specific IgG antibody responses and serum bactericidal titres inchildren following vaccination with a meningococcal A/C polysaccharidevaccine. FEMS Immunol. Med. Microbiol.28:79–85
8. Dagan, R., J. Eskola, C. Leclerc, and O. Leroy.1998. Reduced response tomultiple vaccines sharing common protein epitopes that are administeredsimultaneously to infants. Infect. Immun.66:2093–2098
9. Devine, L. F., W. E. Pierce, T. M. Floyd, et al.1970. Evaluation of group Cmeningococcal polysaccharide vaccine in marine recruits, San Diego, Cali-fornia. Am. J. Epidemiol.92:25–32
10. Fairley, C. K., N. Begg, R. Borrow, A. J. Fox, D. M. Jones, and K. Cartwright.1996. Conjugate meningococcal serogroup A and C vaccine: reactogenicityand immunogenicity in United Kingdom infants. J. Infect. Dis.174:1360–1363
11. Gheesling, L. L., G. M. Carlone, L. Pais, et al.1994. Multicenter comparisonofNeisseria meningitidisserogroup C anti-capsular polysaccharide antibodylevels measured by a standardized enzyme-linked immunosorbent assay.J. Clin. Microbiol.32:1475–1482
12. Goldblatt, D., C. K. Fairley, K. Cartwright, and E. Miller.1996. Interchange-ability of conjugatedHaemophilus influenzaetype b vaccines during primaryimmunisation of infants. Br. Med. J.132:817–818.
13. Goldschneider, I., E. C. Gotschlich, and M. S. Artenstein.1969. Humoralimmunity to the meningococcus. I. The role of humoral antibodies. J. Exp.Med.129:1307–1326
14. Glode, M. P., E. B. Lewin, A. Sutton, C. T. Le, E. C. Gotschlich, and J. B.Robbins.1979. Comparative immunogenicity of vaccines prepared from cap-sular polysaccharides of group CNeisseria meningitidisO-acetyl positive andO-acetyl negative variants andEschericia coliK92 in adult volunteers. J. In-fect. Dis.139:52–59
15. Granoff, D. M., and A. H. Lucas.1995. Laboratory correlates of protectionagainstHaemophilus influenzaetype b disease: importance of assessment ofantibody avidity and immunologic memory. Ann. N. Y. Acad. Sci.754:278–288
16. Granoff, D. M., S. E. Maslanka, G. M. Carlone, et al.1998. A modifiedenzyme-linked immunosorbent assay for the measurement of antibody re-sponses to meningococcal C polysaccharide that correlates with bactericidalresponses. Clin. Diagn. Lab. Immunol.5:479–485
17. Jones, G. R., J. N. Williams, M. Christodoulides, K. Jolley, and J. E. Heck-els.2000. Lack of immunity in University students before an outbreak ofserogroup C meningococcal infection. J. Infect. Dis.181:1172–1175
18. Leach, A., P. A. Twumasi, S. Kumah, et al.1997. Induction of immunologicmemory in Gambian children by vaccination in infancy with a group A plusgroup C meningococcal polysaccharide-protein conjugate vaccine. J. Infect.Dis.175:200–204
19. Macdonald, N. E., S. A. Halperin, B. J. Law, B. Forrest, L. E. Danzig, andD. M. Granoff.1998. Induction of immunologic memory by conjugated vsplain meningococcal C polysaccharide vaccine in toddlers. JAMA280:1685–1689
20. Maslanka, S. E., J. W. Tappero, B. D. Plikaytis, et al.1998. Age-dependentNeisseria meningitidisserogroup C class-specific antibody concentrations andbactericidal titers in sera from young children from Montana immunizedwith a licensed polysaccharide vaccine. Infect. Immun.66:2453–2459.
21. Michon, F., C. H. Huang, E. K. Farley, L. Hronowski, J. Di, and P. C. Fusco.2000. Structure activity studies on group C meningococcal polysaccharide-protein conjugate vaccines: effect ofO-acetylation on the nature of theprotective epitope. Dev. Biol.103:151–160
22. Mitchell, L. A., J. J. Ochnio, C. Glover, A. Y. Lee, M. K. K, Ho, and A. Bell.1996. Analysis of meningococcal serogroup C specific antibody levels inBritish Columbian children and adolescents. J. Infect. Dis.173:1009–1013
23. Neal, K. R., J. S. Nguyen-van-Tam, R. C. Slack, E. B. Kaczmarski, A. White,and D. A. Ala’Aldeen.1999. Seven-week interval between acquisition of ameningococcus and the onset of invasive disease. A case report. Epidemiol.Infect.123:507–509
24. Pichichero, M., P. Anderson, E. Gotschlich, J. Kamm, A. McMullen, and S.Nielsen.1985. Immunogenicity of O-acetyl-negative and -positive polysac-charide vaccines for infections withNeisseria meningitidisgroup C in infants.J. Infect. Dis.152:850–851
25. Ramsay, M., M. Collins, M. Rush, and E. Kaczmarski.1997. The epidemi-ology of meningococcal disease in England and Wales 1996 and 1997. Eu-rosurveillance2:74–7
26. Richmond, P. C., R. Borrow, E. Miller, et al.1999. Meningococcal serogroupC conjugate vaccine in immunogenic in infancy and primes for memory.J. Infect. Dis.179:1569–1572
27. Richmond, P., D. Goldblatt, P. C. Fusco, et al.1999. Safety and immunoge-nicity of a newNeisseria meningitidisserogroup C-tetanus toxoid conjugatevaccine in healthy adults. Vaccine18:641–646
28. Richmond, P., R. Barrow, J. Findlow, S. Martin, R. Morris, K. Cartwright,D. Goldblatt, and E. Miller.2001. Ability of three different meningococcal Cconjugate vaccines to induce immunological memory after a single dose inUK toddlers. J. Infect. Dis.183:160–163
29. Robbins, J. B., R. Schneerson, P. Anderson, and D. H. Smith1996. The 1996Albert Lasker Medical Research Awards. Prevention of systemic infections,especially meningitis, caused byHaemophilus influenzaetype b. Impact onpublic health and implications for other polysaccharide-based vaccines.JAMA276:1181–1185
30. Rosenstein, N. E., B. A. Perkins, D. S. Stephens, et al.1999. The changingepidemiology of meningococcal disease in the United States, 1992–1996.J. Infect. Dis.180:1894–1901
31. Rubinstein, L. J., and K. E. Stein.1988. Murine immune response to theNeisseria meningitidisgroup C capsular polysaccharide. II. Specificity. J. Im-munol.141:4357–4362
32. Steinoff, M. C., E. B. Lewin, E. C. Gotschlich, J. B. Robbins, and PanoramaPediatric Group.1981. Group CNeisseria meningitidisvariant polysaccharidevaccines in children. Infect. Immun.34:144–146
33. Taunay, A. E., R. A. Feldman, C. O. Bastos, P. A. A. Galvao, J. S. Morais,and I. O. Castro.1978. Assessment of the protection conferred by anti-groupC meningococcal polysaccharide vaccine to 6 to 36 month-old children. Rev.Inst. Adolpho Lutz38:77–82.